The U.s.

A book on federal and state marijuana laws next to a judge However, marijuana stocks can still be dangerous At the same time, there are also a laundry list of reasons to stay far, far away from pot stocks. For example, marijuana is still an illicit substance throughout much of North America. The U.S. federal government views it as having no medical benefits, and it’s therefore wholly illegal. This United States’ Schedule I categorization of marijuana comes with a number of inherent disadvantages for U.S. businesses and pot stocks. To begin with, researching cannabis for medical purposes is exceptionally difficult because of its Schedule I status. Also, pot-based businesses are unable to take normal corporate income-tax deductions since they’re selling a federally illegal substance. Finally, banks want little to do with marijuana companies, leaving many cannabis companies to deal solely with cash, which is Green Rush a major security concern and a growth inhibitor.

To read more visit https://www.fool.com/investing/2017/07/10/4-marijuana-stocks-that-should-be-profitable-in-20.aspx

Hartford, Conn.

Connecticut Poll Shows 71 Percent Support for Making Marijuana Legal Residents want to regulate and tax marijuana to help ease state and local budget issues. HARTFORD, Conn. — A new poll by Sacred Heart University shows that 71 percent of Connecticut residents support legalizing and taxing marijuana. The poll was conducted on October 3-12 and surveyed 1,000 Connecticut residents from around the state. This level of support marks a significant increase since the last poll in 2015, which showed 63 percent approval Marijuana Stocks for making marijuana legal for adults, according to a press release. The poll was conducted specifically in the context of the state’s ongoing budget crisis, and the proposal to help fix this issue by regulating and taxing marijuana was the most popular solution. 60 percent of respondents said that the state budget should be fixed by “creating new sources of tax revenue,” while under 33 percent supported cutting services, and a mere 15 percent supported raising existing taxes. “An overwhelming majority of Connecticut residents support regulating and taxing marijuana,” said Sam Tracy, director of the Connecticut Coalition to Regulate Marijuana . “Elected officials should listen to their constituents and legalize marijuana in Connecticut, rather than continue to ignore this source of new jobs, new tax revenue, and improved public health.

To read more visit http://www.cannabisbusinesstimes.com/article/connecticut-poll-shows-71-percent-support-for-making-marijuana-legal/

Nevada Marijuana Sales Beat Projections by $5 Million a Month

By Rick Schettino
NOV 21, 2017

The state of Nevada had projected that its new recreational cannabis market would yield $50 million in additional tax revenue during its first 12 months. They’re on pace to beat that number handily.

The Las Vegas Review-Journal runs the numbers from the Nevada Department of Taxation to find that far more legal cannabis is being sold — and taxed — than the state had anticipated. For the month of September, Nevada dispensaries beat the state’s sales projections by more than $5 million, netting $27 million in sales for the month.

Recreational cannabis became legal in Nevada on July 1, 2017.

July and August also beat projections, with the month of August seeing $33 million in cannabis sales, and July pulling $27.7 million.

Nevada essentially taxes cannabis three times, with a 15% excise tax on wholesale transactions, the standard 8.1% Nevada sales tax, and an additional 10% cannabis retail sales excise tax.

Patients who buy cannabis in Nevada with a medical ID card are not subject to the 10% excise tax.

The taxes collected cover the local government’s cost of regulating the industry, with the remaining funds going to the state’s public education fund.

At the current pace, recreational-use cannabis sales will total more than $350 million in Nevada’s first year in the market.

To read more visit: https://www.potnetwork.com/news/nevada-marijuana-sales-beat-projections-5-million-month

California Issues Commercial Regulations For Cannabis Businesses

By Rick Schettino
NOV 21, 2017

In anticipation of the January 1st “green rush” bonanza of California officially adopting adult recreational use of marijuana, the California Bureau of Cannabis Control has issued 278 pages of rules and regulations governing its sale. In a November 16 release, the bureau announced its guidelines that will combine medicinal sales and recreational sales under one regulatory framework.

These guidelines are just an interim, emergency first set of rules for businesses who intend to begin operation on January 1, 2018. Licenses that any business receives will only be valid for 120 days, in hopes of a permanent framework being prepared in the early months of 2018.

“Now, it’s going to go from the gray areas to the very black and white,” San Diego attorney Michael Cindrich told KUSA. “If you have a state license, you’re legal. If you don’t have a state license, you’re illegal.”

Notably, dispensaries are required to be located at least 600 feet from a school under the new rules. Dispensaries cannot remain open past 10 p.m. and must have 24-hour video surveillance.

The regulations have consumer ramifications as well. Serving sizes cannot exceed more than 10 mg of THC, and products cannot be manufactured in the shape of animals, fruits, or other shapes that might appeal to children.

The big snag is the requirement that dispensaries receive a legal permit from local authorities before they can apply for a state permit. Most localities, including Los Angeles and San Francisco, will not have their permit process in place by January 1.

The California cannabis market is currently valued at about $7 billion.

To read more visit: https://www.potnetwork.com/news/california-issues-commercial-regulations-cannabis-businesses

New Research Suggests Cannabis Could Help Heart Failure Patients

Doctors expected that cannabis use would pose a risk for heart failure patients, but found that the opposite was true. They also found that cannabis users were less likely to die in the hospital.

A research team has made the discovery that cannabis may have benefits for those suffering from heart problems. At a recent meeting of the American Heart Association’s Scientific Sessions, Dr. Oluwole Adegbala, medical resident at Englewood Hospital and Medical Center in New Jersey, presented the findings of an unpublished study on the link between cannabis use and heart failure. Previous research has suggested links between cannabis use and heart problems, and the research team fully expected to find evidence supporting claims that cannabis users were at greater risk of heart-related health problems.

Instead, the team was “surprised” to find that cannabis users were less likely to experience atrial fibrillation (A-fib), an irregularity of the heartbeat that can worsen the symptoms of heart failure, compared to non-users. Dr. Adegbala and his colleagues analyzed a database of over 6 million patients suffering from heart failure who were admitted to the hospital between 2007 and 2014. Around 23,000 of these patients reportedly used cannabis but were not considered dependent on the drug, and another 1,200 patients were considered dependent cannabis users, LiveScience reports.

The research team found that the non-dependent cannabis users were 18% less likely than non-users to experience A-fib, and were also 46% less likely to die in the hospital. The dependent cannabis users were 31% less likely to develop A-fib and 58% less likely to die in the hospital than non-users. Researchers adjusted their data to account for age, socioeconomic status, and use of other drugs, and discovered that their findings were still solid.

Dr. Adegbala told LiveScience that his team was not able to identify the exact reasons why cannabis might decrease the risk of A-fib or mortality for heart failure patients. Previous research in animals has found that high blood pressure and atherosclerosis, two risk factors for A-fib, can be reduced by activating cannabinoid receptors. Dr. Adegbala also noted that cannabidiol can reduce inflammation, which is another risk factor for A-fib. Despite their positive findings, the research team does not recommend that heart failure patients begin using cannabis as a treatment until further research can be conducted to support or refute the findings of this study.

To read more visit: https://merryjane.com/news/new-research-suggests-cannabis-could-help-heart-failure-patients

Is A Holding Company That’s Invested In More Than A Half-dozen Cannabidiol (cbd)-product Companies For The Pharmaceutical, Nutraceutical, Cosmeceutical, Or Industrial Hemp Industries.

Rolling dice that read "buy" or "sell" on top of a digital stock chart. ( NASDAQOTH:MJNA ). While GW Pharmaceuticals currently holds the title of being the largest pot stock by a mile, Medical Marijuana, Inc. holds the distinction of being the first publicly listed marijuana stock. Unlike most marijuana stocks that tend to focus on developing a handful of products or a small portfolio of cannabinoid-based drugs, Medical Marijuana, Inc. is a holding company that’s invested in more than a half-dozen cannabidiol (CBD)-product companies for the pharmaceutical, nutraceutical, cosmeceutical, or industrial hemp industries. The company’s eight listed subsidiaries and investments include: HempMeds, which offers marketing and sales of CBD-based products in the U.S.; Kannaway, which specializes in hemp-based botanical products; KannaLife Sciences, which is a cannabinoid-based drug developer; Axim Biotechnologies, which is also a developer of cannabinoid-based medicines; MPS International, a security consultation service for the weed industry; Wellness Managed Services, which provides support services to the pot industry. The most obvious reason marijuana stock investors are Green Rush likely excited about a company like Medical Marijuana, Inc. is its portfolio diversity. Its complete ownership of HempMeds and investments in KannaLife Sciences and Axim Biotechnologies gives the company access to retail CBD product sales, as well as the opportunity to earn significant investment rewards if Axim’s and KannaLife’s cannabinoid-based products succeed in clinical trials.

To read more visit https://www.fool.com/investing/2017/06/16/better-know-a-marijuana-stock-medical-marijuana-in.aspx

Truth Is, I Won’t Touch A Cannabis Company That Doesn’t Have A War Chest Of Capital Going Into 2018.

And only those companies that are well capitalized will be able to successfully compete in 2018. Truth is, I won’t touch a cannabis company that doesn’t have a war chest of capital going into 2018. The market is getting too competitive, and those that are not well capitalized will be out of business by the end of next year. Market share is also incredibly important. This is where Canada really shines, as the biggest players in this market also have exposure in other countries, including the U.S., Germany, Colombia, Israel, and Australia. Medical marijuana And, of course, management is key. In fact, I often say that it’s management in which I invest, not companies. Similar to the way we’ve seen this factor play a role in the success of stocks like Tesla (NASDAQ: TSLA), Amazon (NASDAQ: AMZN), and Apple (NASDAQ: AAPL), the same holds true of the cannabis space. As an expert in this field, I’ve come to know and respect the most successful management teams in this space.

To read more visit https://www.energyandcapital.com/articles/the-top-7-cannabis-stocks-for-2018/6104

Federal Law And That The Approach To Enforcement By The U.s.

marijuana-related activities are expected to: Describe the nature of the public company’s involvement in the U.S. marijuana industry and include the disclosures indicated based on the nature of such involvement as either direct, indirect or ancillary (as discussed below); Explain that marijuana remains illegal under U.S. federal law and that the approach to enforcement by the U.S. federal government is subject to change, as well as a discussion of resultant risks of such change including the potential for adverse enforcement action; State whether and how the public company’s marijuana-related activities are conducted in a manner consistent with any U.S. federal enforcement priorities; and Given the illegality of marijuana under U.S. federal law, discuss the public company’s ability to access both public and private capital markets and indicate what financing options are available to support continuing operations. For public companies directly Green Rush engaged in the cultivation or distribution of marijuana in the U.S. in accordance with a state license, the following disclosure is required: An outline of the regulations for the U.S. state(s) in which the public company operates and confirm how the public company complies with applicable licensing requirements and the applicable regulatory framework; A discussion of the public company’s program for monitoring compliance with U.S. state law on an ongoing basis and its internal compliance mechanisms; and Disclosure of any material non-compliance, as well as material citations or notices of violation. For public companies with indirect involvement in cultivation or distribution of marijuana by way of a non-controlling investment in an entity who is directly involved in the U.S.

To read more visit https://www.lexology.com/library/detail.aspx?g=2e0af220-ae61-4be9-8f4b-55ee4e14b12b

Municipalities Will Also Levy Sales Tax And A Business Tax, Which Could Be Anywhere From 1 To 20 Percent, On Gross Receipts.  Business Taxes On Recreational Marijuana Have Been Approved By Voters In 61 California Cities And Counties, According To The Report.

The credit rating agency estimates state and local taxes on marijuana, which will become Marijuana Stocks legal in California on Jan. 1., could be as high as 45 percent in some cases. It would trail only Washington state, which levies a 50 percent tax on marijuana. “The existing black market for cannabis may prove a formidable competitor to legal markets if new taxes lead to higher prices than available from illicit sources,” the report says. Recreational marijuana will be taxed on both the state and local level, contributing to the potential for high rates. California will impose a 15 percent excise tax, as well as cultivation taxes. Municipalities will also levy sales tax and a business tax, which could be anywhere from 1 to 20 percent, on gross receipts.  Business taxes on recreational marijuana have been approved by voters in 61 California cities and counties, according to the report. These high tax rates have the potential to drive customers toward the black market. The state is the nation’s epicenter of marijuana growing and has long provided black market pot. The report states that Colorado, Oregon and Washington all reduced tax rates after the commencement of legalization to shift customers back toward the legal market. California will implement a statewide framework for marijuana legalization, but each municipality must decide whether it wants to house marijuana businesses and, if so, map out its own regulations and tax structure.

To read more visit https://www.washingtonpost.com/news/post-nation/wp/2017/10/30/high-taxes-could-drive-up-marijuana-prices-and-bolster-the-black-market-in-california-analysis-says/

Among The Topics To Be Considered, According To The Commission, Are How Legalization Might Affect The Opioid Crisis, Crime Rates, Children’s Health, Dui Accidents, Taxation Policies And New Hampshire’s Brand.

New Hampshire Lawmakers on Marijuana Panel Begin Examination of Legalization The commission tasked with exploring legalization in the state will issue its final report next November. A commission tasked with exploring marijuana legalization in New Hampshire held its first meeting Tuesday, setting off a yearlong examination process ahead of its final report next November. Created by House Bill 215, the commission is charged with looking at what might happen if the state legalized marijuana, regulating and taxing it like alcohol, along the model of other states. STATE BY STATE: New Hampshire Cannabis News The goal is broad. Among the topics to be considered, according to the commission, are how legalization might affect the opioid crisis, crime rates, children’s health, DUI accidents, taxation policies and New Hampshire’s brand. “To me, in simple form, Green Rush I think it’s our job to identify the good, the bad and the ugly of legalization,” Rep. Patrick Abrami, the commission’s chairman, said at the meeting Tuesday. The commission will reach out to states that have already undertaken the effort, such as Colorado, which implemented legalization in 2014, and Massachusetts, which will roll out its legalization effort next summer. Members will try to set up video conferences with state officials over Skype, said Abrami, a Stratham Republican.

To read more visit http://www.cannabisbusinesstimes.com/article/new-hampshire-lawmakers-begin-examination-of-legalization/